Czechia· CZ-0259424
PIMAFUCIN
A natamycin product containing natamycin, registered in Czechia by CHEPLAPHARM Arzneimittel GmbH, Greifswald. The same ATC class is registered in 2 of our 19 countries.
Checked against SÚKL (Czech Republic) on
Informational only — not a medical device.
Where it is registered
Natamycin is registered in 2 of 19 countries.
Countries holding a registration under ATC G01AA02 (natamycin), each read from that country’s own register.
- This record: Czechia, from SÚKL (Czech Republic)
- 2 of them publish a price we can compare per daily dose
Natamycin · ATC G01AA02
2 / 19 countries
- Czechiaprice
- Finlandprice
The record
At a glance
SÚKL (Czech Republic)- Active substance
- NATAMYCIN
- Manufacturer
- CHEPLAPHARM Arzneimittel GmbH, Greifswald
- Country
- Czechia (CZ)
- ATC code
- G01AA02
- ATC class
- Natamycin
- Defined daily dose
- 25 mg, V
- Reimbursed
- Not published by this register
- Source register
- SÚKL (Czech Republic)
- Last checked
- September 28, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Natamycin in 6 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandPimafucinCheplapharm Arzneimittel GmbH
- United KingdomNatacyn 5% ophthalmic suspensionImported (United States)
- Japanピマリシン千寿製薬
- United StatesNATACYNHarrow Eye, LLC
- PolandPimafucinCHEPLAPHARM Arzneimittel GmbH
- NorwayNatacyn
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Finland · Pimafucin
- Hungary · Pimafucin
- Poland · Pimafucin
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of SÚKL (Czech Republic). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/2432b859-b460-482e-9aae-46c8543660a9 GET /v1/drugs/2432b859-b460-482e-9aae-46c8543660a9?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "VAG GLB",
"source": "sukl",
"strength": "100MG",
"pack_size": "3",
"substance": "NATAMYCIN",
"cz_kod_sukl": "0259424",
"product_type": "CH",
"substance_codes": "960",
"registration_state": "R",
"registration_number": "54/1202/94-C"
}See everything about natamycin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.